F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Hepatic steatosis

1	Metabolic dysfunction associated fatty liver disease: The new nomenclature and its impact 1/12/2023 10:19:09 AM \| Browse: 146 \| Download: 309
2	Hepatic steatosis with mass effect: A case report 10/21/2022 2:24:59 AM \| Browse: 260 \| Download: 886
3	Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerations 10/18/2022 8:29:59 AM \| Browse: 253 \| Download: 523
4	Growing challenge of post-liver transplantation non-alcoholic fatty liver disease 9/13/2022 3:28:02 AM \| Browse: 317 \| Download: 702
5	Nonalcoholic fatty liver disease and diabetes 9/9/2022 3:45:24 PM \| Browse: 311 \| Download: 623
6	Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease 8/26/2022 9:51:35 AM \| Browse: 240 \| Download: 382
7	Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease 4/30/2022 5:08:22 AM \| Browse: 295 \| Download: 649
8	Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations 4/22/2022 10:52:23 AM \| Browse: 338 \| Download: 581
9	Hepatobiliary manifestations in inflammatory bowel disease: A practical approach 2/22/2022 9:25:37 AM \| Browse: 217 \| Download: 333
10	Influencing factors for hepatic fat accumulation in patients with type 2 diabetes mellitus 9/10/2021 7:23:16 AM \| Browse: 321 \| Download: 788
11	Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond 4/29/2021 2:12:02 AM \| Browse: 334 \| Download: 631
12	Evaluation of controlled attenuation parameter in assessing hepatic steatosis in patients with autoimmune liver diseases 12/30/2020 1:59:10 PM \| Browse: 501 \| Download: 1115
13	MANF ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism 3/14/2020 3:03:29 PM \| Browse: 764 \| Download: 1231
14	Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1/AMPK and NF-κB signaling pathways 9/12/2019 8:50:34 AM \| Browse: 591 \| Download: 1371
15	Accuracy of multi-echo Dixon sequence in quantification of hepatic steatosis in Chinese children and adolescents 3/28/2019 9:14:41 AM \| Browse: 890 \| Download: 1474
16	Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway 3/28/2019 9:14:40 AM \| Browse: 756 \| Download: 1158
17	Hemodynamic changes in hepatic sinusoids of hepatic steatosis mice 3/20/2019 5:32:10 AM \| Browse: 796 \| Download: 1416
18	Risk factors for hepatic steatosis in adults with cystic fibrosis: Similarities to non-alcoholic fatty liver disease 1/26/2018 8:09:36 AM \| Browse: 737 \| Download: 1161
19	Clinical epidemiology and disease burden of nonalcoholic fatty liver disease 12/20/2017 2:49:19 AM \| Browse: 1266 \| Download: 1404
20	Fatty liver without a large “belly”: Magnified review of non-alcoholic fatty liver disease in non-obese patients 8/14/2017 1:56:00 AM \| Browse: 931 \| Download: 1458
21	S-1 induced hepatic steatosis in patients with pancreatic cancer: Retrospective analysis 8/10/2017 11:54:13 PM \| Browse: 1200 \| Download: 1621
22	Is hepatic steatosis associated with left ventricular mass index increase in the general population? 7/5/2017 4:40:08 AM \| Browse: 873 \| Download: 1513
23	Antioxidant dietary approach in treatment of fatty liver: New insights and updates 6/20/2017 12:12:52 PM \| Browse: 1009 \| Download: 1670
24	Embrionary way to create a fatty liver in portal hypertension 5/16/2017 6:56:36 AM \| Browse: 1219 \| Download: 1810
25	Chronic exposure to ethanol causes steatosis and inflammation in zebrafish liver 3/13/2017 1:20:00 PM \| Browse: 1092 \| Download: 1328
26	Sitagliptin in patients with non-alcoholic steatohepatitis: A randomized, placebo-controlled trial 1/5/2017 11:10:00 AM \| Browse: 1429 \| Download: 2569
27	Quality of life 10 years after liver transplantation: The impact of graft histology 12/14/2016 2:15:00 PM \| Browse: 1002 \| Download: 1141
28	Hepatic steatosis and fibrosis: Non-invasive assessment 12/6/2016 5:24:00 PM \| Browse: 1047 \| Download: 1211
29	Retrospective study of the associations between hepatitis C virus infection and metabolic factors 10/25/2016 8:46:00 AM \| Browse: 1382 \| Download: 2018
30	Steatotic livers are susceptible to normothermic ischemia-reperfusion injury from mitochondrial Complex-Ⅰ dysfunction 5/19/2016 9:54:00 AM \| Browse: 951 \| Download: 1763
31	Fatty liver disease: Disparate predictive ability for cardiometabolic risk and all-cause mortality 12/24/2015 11:11:00 AM \| Browse: 986 \| Download: 1272
32	Bile acid receptors and nonalcoholic fatty liver disease 12/4/2015 3:24:00 PM \| Browse: 1256 \| Download: 1844
33	Ezetimibe improves hepatic steatosis in relation to autophagy in obese and diabetic rats 7/8/2015 12:00:00 PM \| Browse: 1326 \| Download: 2115
34	Nonalcoholic fatty liver disease, spleen and psoriasis: New aspects of low-grade chronic inflammation 6/18/2015 5:31:00 PM \| Browse: 1221 \| Download: 1369
35	Non-alcoholic fatty liver disease in 2015 6/16/2015 2:22:00 PM \| Browse: 1115 \| Download: 1585
36	Cholecystectomy is independently associated with nonalcoholic fatty liver disease in an Asian population 5/30/2015 1:35:00 PM \| Browse: 1169 \| Download: 1951
37	Delayed ethanol elimination and enhanced susceptibility to ethanol-induced hepatosteatosis after liver resection 1/6/2015 9:08:00 AM \| Browse: 973 \| Download: 1366
38	MK-0626, a selective DPP-4 inhibitor, attenuates hepatic steatosis in ob/ob mice 12/5/2014 11:43:00 AM \| Browse: 1069 \| Download: 1259
39	Liver transplantation and non-alcoholic fatty liver disease 11/17/2014 3:13:00 PM \| Browse: 1151 \| Download: 1096
40	Protective effects of two Lactobacillus plantarum strains in hyperlipidemic mice 9/16/2014 9:55:00 AM \| Browse: 1038 \| Download: 972
41	Splanchnic-aortic inflammatory axis in experimental portal hypertension 9/11/2014 8:40:00 PM \| Browse: 977 \| Download: 931
42	Antiviral treatment of hepatitis C virus infection and factors affecting efficacy 9/11/2014 8:39:00 PM \| Browse: 1146 \| Download: 1054
43	Modulation of hepatic steatosis by dietary fatty acids 9/2/2014 5:02:00 PM \| Browse: 1117 \| Download: 924
44	Exenatide improves hepatic steatosis by enhancing lipid use in adipose tissue in nondiabetic rats 9/1/2014 5:04:00 PM \| Browse: 1017 \| Download: 1175
45	Interaction between hepatitis C virus and metabolic factors 9/1/2014 2:51:00 PM \| Browse: 1121 \| Download: 803
46	Pooled genetic analysis in ultrasound measured non-alcoholic fatty liver disease in Indian subjects: a pilot study 8/26/2014 2:42:00 PM \| Browse: 1081 \| Download: 1137

Page 1 of 1 ( 46 items )
<<
1
>>

1	Metabolic dysfunction associated fatty liver disease: The new nomenclature and its impact 1/12/2023 10:19:09 AM \| Browse: 146 \| Download: 309
2	Hepatic steatosis with mass effect: A case report 10/21/2022 2:24:59 AM \| Browse: 260 \| Download: 886
3	Interplay between metabolic dysfunction-associated fatty liver disease and chronic kidney disease: Epidemiology, pathophysiologic mechanisms, and treatment considerations 10/18/2022 8:29:59 AM \| Browse: 253 \| Download: 523
4	Growing challenge of post-liver transplantation non-alcoholic fatty liver disease 9/13/2022 3:28:02 AM \| Browse: 317 \| Download: 702
5	Nonalcoholic fatty liver disease and diabetes 9/9/2022 3:45:24 PM \| Browse: 311 \| Download: 623
6	Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease 8/26/2022 9:51:35 AM \| Browse: 240 \| Download: 382
7	Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease 4/30/2022 5:08:22 AM \| Browse: 295 \| Download: 649
8	Testosterone therapy reduces hepatic steatosis in men with type 2 diabetes and low serum testosterone concentrations 4/22/2022 10:52:23 AM \| Browse: 338 \| Download: 581
9	Hepatobiliary manifestations in inflammatory bowel disease: A practical approach 2/22/2022 9:25:37 AM \| Browse: 217 \| Download: 333
10	Influencing factors for hepatic fat accumulation in patients with type 2 diabetes mellitus 9/10/2021 7:23:16 AM \| Browse: 321 \| Download: 788
11	Metabolic and cardiovascular complications after virological cure in hepatitis C: What awaits beyond 4/29/2021 2:12:02 AM \| Browse: 334 \| Download: 631
12	Evaluation of controlled attenuation parameter in assessing hepatic steatosis in patients with autoimmune liver diseases 12/30/2020 1:59:10 PM \| Browse: 501 \| Download: 1115
13	MANF ameliorates steatosis in HepG2 cells by regulating hepatic lipid metabolism 3/14/2020 3:03:29 PM \| Browse: 764 \| Download: 1231
14	Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1/AMPK and NF-κB signaling pathways 9/12/2019 8:50:34 AM \| Browse: 591 \| Download: 1371
15	Accuracy of multi-echo Dixon sequence in quantification of hepatic steatosis in Chinese children and adolescents 3/28/2019 9:14:41 AM \| Browse: 890 \| Download: 1474
16	Ursodeoxycholic acid ameliorates hepatic lipid metabolism in LO2 cells by regulating the AKT/mTOR/SREBP-1 signaling pathway 3/28/2019 9:14:40 AM \| Browse: 756 \| Download: 1158
17	Hemodynamic changes in hepatic sinusoids of hepatic steatosis mice 3/20/2019 5:32:10 AM \| Browse: 796 \| Download: 1416
18	Risk factors for hepatic steatosis in adults with cystic fibrosis: Similarities to non-alcoholic fatty liver disease 1/26/2018 8:09:36 AM \| Browse: 737 \| Download: 1161
19	Clinical epidemiology and disease burden of nonalcoholic fatty liver disease 12/20/2017 2:49:19 AM \| Browse: 1266 \| Download: 1404
20	Fatty liver without a large “belly”: Magnified review of non-alcoholic fatty liver disease in non-obese patients 8/14/2017 1:56:00 AM \| Browse: 931 \| Download: 1458
21	S-1 induced hepatic steatosis in patients with pancreatic cancer: Retrospective analysis 8/10/2017 11:54:13 PM \| Browse: 1200 \| Download: 1621
22	Is hepatic steatosis associated with left ventricular mass index increase in the general population? 7/5/2017 4:40:08 AM \| Browse: 873 \| Download: 1513
23	Antioxidant dietary approach in treatment of fatty liver: New insights and updates 6/20/2017 12:12:52 PM \| Browse: 1009 \| Download: 1670
24	Embrionary way to create a fatty liver in portal hypertension 5/16/2017 6:56:36 AM \| Browse: 1219 \| Download: 1810
25	Chronic exposure to ethanol causes steatosis and inflammation in zebrafish liver 3/13/2017 1:20:00 PM \| Browse: 1092 \| Download: 1328
26	Sitagliptin in patients with non-alcoholic steatohepatitis: A randomized, placebo-controlled trial 1/5/2017 11:10:00 AM \| Browse: 1429 \| Download: 2569
27	Quality of life 10 years after liver transplantation: The impact of graft histology 12/14/2016 2:15:00 PM \| Browse: 1002 \| Download: 1141
28	Hepatic steatosis and fibrosis: Non-invasive assessment 12/6/2016 5:24:00 PM \| Browse: 1047 \| Download: 1211
29	Retrospective study of the associations between hepatitis C virus infection and metabolic factors 10/25/2016 8:46:00 AM \| Browse: 1382 \| Download: 2018
30	Steatotic livers are susceptible to normothermic ischemia-reperfusion injury from mitochondrial Complex-Ⅰ dysfunction 5/19/2016 9:54:00 AM \| Browse: 951 \| Download: 1763
31	Fatty liver disease: Disparate predictive ability for cardiometabolic risk and all-cause mortality 12/24/2015 11:11:00 AM \| Browse: 986 \| Download: 1272
32	Bile acid receptors and nonalcoholic fatty liver disease 12/4/2015 3:24:00 PM \| Browse: 1256 \| Download: 1844
33	Ezetimibe improves hepatic steatosis in relation to autophagy in obese and diabetic rats 7/8/2015 12:00:00 PM \| Browse: 1326 \| Download: 2115
34	Nonalcoholic fatty liver disease, spleen and psoriasis: New aspects of low-grade chronic inflammation 6/18/2015 5:31:00 PM \| Browse: 1221 \| Download: 1369
35	Non-alcoholic fatty liver disease in 2015 6/16/2015 2:22:00 PM \| Browse: 1115 \| Download: 1585
36	Cholecystectomy is independently associated with nonalcoholic fatty liver disease in an Asian population 5/30/2015 1:35:00 PM \| Browse: 1169 \| Download: 1951
37	Delayed ethanol elimination and enhanced susceptibility to ethanol-induced hepatosteatosis after liver resection 1/6/2015 9:08:00 AM \| Browse: 973 \| Download: 1366
38	MK-0626, a selective DPP-4 inhibitor, attenuates hepatic steatosis in ob/ob mice 12/5/2014 11:43:00 AM \| Browse: 1069 \| Download: 1259
39	Liver transplantation and non-alcoholic fatty liver disease 11/17/2014 3:13:00 PM \| Browse: 1151 \| Download: 1096
40	Protective effects of two Lactobacillus plantarum strains in hyperlipidemic mice 9/16/2014 9:55:00 AM \| Browse: 1038 \| Download: 972
41	Splanchnic-aortic inflammatory axis in experimental portal hypertension 9/11/2014 8:40:00 PM \| Browse: 977 \| Download: 931
42	Antiviral treatment of hepatitis C virus infection and factors affecting efficacy 9/11/2014 8:39:00 PM \| Browse: 1146 \| Download: 1054
43	Modulation of hepatic steatosis by dietary fatty acids 9/2/2014 5:02:00 PM \| Browse: 1117 \| Download: 924
44	Exenatide improves hepatic steatosis by enhancing lipid use in adipose tissue in nondiabetic rats 9/1/2014 5:04:00 PM \| Browse: 1017 \| Download: 1175
45	Interaction between hepatitis C virus and metabolic factors 9/1/2014 2:51:00 PM \| Browse: 1121 \| Download: 803
46	Pooled genetic analysis in ultrasound measured non-alcoholic fatty liver disease in Indian subjects: a pilot study 8/26/2014 2:42:00 PM \| Browse: 1081 \| Download: 1137